ESC Professional Premium Access

Association between implanted cardioverter-defibrillator and mortality for patients with left ventricular ejection fraction near 35%

Topic: Implantable Cardioverter-Defibrillator (ICD)

Congress Presentation

About the speaker

Associate Professor Jason Wasfy

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)
0 follower

6 more presentations in this session

Efficacy of implantable cardioverter-defibrillator in non-ischemic systolic heart failure in patients with and without chronic kidney disease: an extended follow-up analysis of the DANISH trial

Speaker: Doctor S. N Doi (Copenhagen, DK)


A systematic review of Australian hospitals' policies on the deactivation of implantable cardioverter defibrillators

Speaker: Doctor D. Grose (Melbourne, AU)


Effect of implantable cardioverter-defibrillator in non-ischaemic systolic heart failure according to the Heart Failure Collaboratory Medical Therapy Score: extended follow-up of the DANISH trial

Speaker: Doctor A. Yafasova (Copenhagen, DK)


Left bundle branch area pacing in patients with CRT indication: short-term results & 1-year follow-up

Speaker: Doctor V. Kataria (New Delhi, IN)


Role of fragmented QRS complex in the prognosis of patients undergoing cardiac resynchronization therapy. A new red flag to look for?

Speaker: Doctor C. Rodriguez-Lopez (Madrid, ES)


Access the full session

Devices and heart failure: ICD and CRT

Speakers: Associate Professor J. Wasfy, Doctor S. N Doi, Doctor D. Grose, Doctor A. Yafasova, Doctor V. Kataria...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb